BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10961891)

  • 1. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes.
    Anagnostopoulos I; Hansmann ML; Franssila K; Harris M; Harris NL; Jaffe ES; Han J; van Krieken JM; Poppema S; Marafioti T; Franklin J; Sextro M; Diehl V; Stein H
    Blood; 2000 Sep; 96(5):1889-99. PubMed ID: 10961891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
    Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
    J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group.
    von Wasielewski R; Werner M; Fischer R; Hansmann ML; Hübner K; Hasenclever D; Franklin J; Sextro M; Diehl V; Georgii A
    Am J Pathol; 1997 Mar; 150(3):793-803. PubMed ID: 9060817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults.
    Huppmann AR; Nicolae A; Slack GW; Pittaluga S; Davies-Hill T; Ferry JA; Harris NL; Jaffe ES; Hasserjian RP
    Am J Surg Pathol; 2014 Mar; 38(3):316-24. PubMed ID: 24525501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell-derived nodular type.
    Hansmann ML; Stein H; Dallenbach F; Fellbaum C
    Am J Pathol; 1991 Jan; 138(1):29-36. PubMed ID: 1987769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.
    Ha CS; Kavadi V; Dimopoulos MA; Hagemeister FB; Osborne BM; Fuller LM; Smith TL; Hess MA; McLaughlin PW; Cabanillas FF; Cox JD
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):329-34. PubMed ID: 10030257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent lymphocyte predominance Hodgkin's disease and T-cell lymphoma. A report of three cases.
    Delabie J; Greiner TC; Chan WC; Weisenburger DD
    Am J Surg Pathol; 1996 Mar; 20(3):355-62. PubMed ID: 8772790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodular lymphocyte-predominant hodgkin lymphoma with atypical T cells: a morphologic variant mimicking peripheral T-cell lymphoma.
    Sohani AR; Jaffe ES; Harris NL; Ferry JA; Pittaluga S; Hasserjian RP
    Am J Surg Pathol; 2011 Nov; 35(11):1666-78. PubMed ID: 21997687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease.
    Lin P; Medeiros LJ; Wilder RB; Abruzzo LV; Manning JT; Jones D
    Histopathology; 2004 Jun; 44(6):561-9. PubMed ID: 15186271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte predominant Hodgkin's disease--a workshop report. European Task Force on Lymphoma.
    Sextro M; Diehl V; Franklin J; Hansmann ML; Anagnostopoulos I; Marafioti T; Stein H
    Ann Oncol; 1996; 7 Suppl 4():61-5. PubMed ID: 8836412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extranodal lymphocyte predominance Hodgkin's disease. Clinical and pathologic features.
    Siebert JD; Stuckey JH; Kurtin PJ; Banks PM
    Am J Clin Pathol; 1995 Apr; 103(4):485-91. PubMed ID: 7726148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte predominance Hodgkin's disease: the use of bcl-6 and CD57 in diagnosis and differential diagnosis.
    Kraus MD; Haley J
    Am J Surg Pathol; 2000 Aug; 24(8):1068-78. PubMed ID: 10935647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
    Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
    J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary T-cell lymphoma in the setting of nodular lymphocyte predominance Hodgkin's disease.
    Tefferi A; Wiltsie JC; Kurtin PJ
    Am J Hematol; 1992 Jul; 40(3):232-3. PubMed ID: 1609779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma.
    Grossman DM; Hanson CA; Schnitzer B
    Am J Surg Pathol; 1991 Jul; 15(7):668-76. PubMed ID: 2058762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus infection is inversely correlated with the expression of retinoblastoma protein in Reed-Sternberg cells in classic Hodgkin lymphoma.
    Al-Salam S; Awwad A; Alashari M
    Int J Clin Exp Pathol; 2014; 7(11):7508-17. PubMed ID: 25550786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype.
    Chang KC; Khen NT; Jones D; Su IJ
    Hum Pathol; 2005 Jul; 36(7):747-55. PubMed ID: 16084943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nodular lymphocyte predominance Hodgkin's disease and its differential diagnosis].
    Carbonnelle A; Delarue R; Canioni D; Brousse N
    Ann Pathol; 2004 Apr; 24(2):136-48; quiz 135. PubMed ID: 15220833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center.
    Menke JR; Spinner MA; Natkunam Y; Warnke RA; Advani RH; Gratzinger DA
    Arch Pathol Lab Med; 2021 Jun; 145(6):753-758. PubMed ID: 32991677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathologic characteristics and prognosis of neoplastic cell-rich mixed cellularity classic Hodgkin lymphoma].
    Hou WH; Wei P; Xie JL; Zheng YY; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):708-713. PubMed ID: 29050074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.